TNK2 抑制剂 (R) -9bMS 通过向 Aurora B 的方式,通过线索性失败引起多体化
Mayu Murata1, Hiroki Kuwajima1, Junna Tanaka1
1Laboratory of Biochemistry and Molecular Biology, Kyoto Pharmaceutical University, Kyoto, Japan.
Cell biochemistry and function
|December 5, 2024
概括
像 (R) - 9bMS这样的TNK2抑制剂可以通过Aurora B激酶抑制诱导多体细胞,而不是TNK2抑制,从而导致癌症的进展. 高度有可能促进癌症的发展.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- TNK2 (Tyrosine kinase) 与瘤发生有关,是癌症化疗的目标.
- 像XMD16-5这样的TNK2抑制剂可以通过向更高度的Aurora B激酶来抑制细胞动力学.
- 细胞动力学失败导致多倍体细胞,这可以推动癌症的发展和进展.
研究的目的:
- 调查TNK2抑制剂 (R) -9bMS是否通过诱导异常细胞分裂促进恶性进展.
- 检查 (R) -9bMS对细胞分裂,Aurora B自酸化和殖民地形成的影响.
主要方法:
- 细胞计数和对癌细胞系的显微观测 (A431,HeLa S3,HCT116,MCF7).
- 流细胞计测试以评估DNA含量和中心细胞数量.
- 时间间隔成像分析线粒体事件.
- 在TNK2的淘汰实验中.
主要成果:
- (R) - 9bMS治疗减少了细胞数量,并诱导了多核,扩大的细胞,增加了DNA含量和中心体.
- 线粒细胞衰竭,包括滑落和细胞动力学失败,导致了多化.
- 抑制TNK2对多核细胞的影响有限,而 (R) -9bMS减少了Aurora B酸化.
- (R-9bMS) 促进了对位独立的殖民地形成,这是癌症的标志.
结论:
- TNK2 抑制剂 (R)-9bMS 和 XMD16-5 通过 Aurora B 激酶抑制诱导多倍化,而不是直接抑制 TNK2.
- 高度的 (R) -9bMS可能会促进癌症的发展和恶性进展.
- 建议在使用TNK2抑制剂治疗非TNK2突变驱动的癌症时谨慎使用,特别是在较高剂量时.
更多相关视频
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
11.0K
08:33Combining Mitotic Cell Synchronization and High Resolution Confocal Microscopy to Study the Role of Multifunctional Cell Cycle Proteins During Mitosis
Published on: December 5, 2017
14.2K
相关概念视频
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Meiosis II
43.3K
Meiosis II entails cell division and segregation of the sister chromatids, resulting in the production of four unique haploid gametes. The steps for meiosis II are similar to mitosis, except that meiosis II occurs in haploid cells, whereas mitosis occurs in diploid cells.
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...
The timing and cell division patterns of meiosis differ between males and females. In male meiosis, the centrosomes are part of the formation of the meiotic spindle. However, in oocytes, including that of humans, Drosophila,...
43.3K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
